STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results

被引：0

作者：

Hopkin, Robert J. ^{[1
]}

Ganesh, Jaya ^{[2
]}

Deegan, Patrick ^{[3
]}

Goker-Alpan, Ozlem ^{[4
]}

Bernat, John ^{[5
]}

Wilcox, William R. ^{[6
]}

Pahl, Madeleine V. ^{[7
]}

Whitley, Chester B. ^{[8
]}

Hughes, Derralynn ^{[9
]}

Nicholls, Kathleen ^{[10
]}

Cao, Liching ^{[11
]}

Chen, Michael ^{[11
]}

Shiue, Lisa H. ^{[11
]}

Bowden, Emma ^{[11
]}

Jaggumantri, Sravan ^{[11
]}

Passalacqua, Cristobal ^{[11
]}

Souberbielle, Bernard ^{[11
]}

Cockroft, Bettina M. ^{[11
]}

机构：

[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA

[2] Icahn Sch Med Mt Sinai, New York, NY USA

[3] Addenbrookes Hosp, Cambridge, England

[4] Lysosomal & Rare Disorders Res & Treatment Ctr In, Fairfax, VA USA

[5] Univ Iowa, Iowa City, IA USA

[6] Emory Univ, Human Genet, Atlanta, GA USA

[7] Univ Calif Irvine, Orange, CA USA

[8] Univ Minnesota, Minneapolis, MN USA

[9] UCL, London, England

[10] Royal Melbourne Hosp, Parkville, Australia

[11] Sangamo Therapeut Inc, Brisbane, CA USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2022.107152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

169

引用

页码：61 / 62

页数：2

共 50 条

[31] Phase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia
Lee, Mark Hong
Kim, Sung-Yong
LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2268 - 2274
[32] A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia
Lee, Mark
Kim, Sung-Yong
BLOOD, 2015, 126 (23)
[33] Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
Kim, Tae Hyun
Park, Joong-Won
Kim, Yeon-Joo
Kim, Bo Hyun
Woo, Sang Myung
Moon, Sung Ho
Kim, Sang Soo
Koh, Young-Hwan
Lee, Woo Jin
Park, Sang Jae
Kim, Joo-Young
Kim, Dae Yong
Kim, Chang-Min
CANCER RESEARCH AND TREATMENT, 2015, 47 (01): : 34 - 45
[34] Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy
Goebel, FD
Hemmer, R
Schmit, JC
Bogner, JR
de Clercq, E
Witvrouw, M
Pannecouque, C
Valeyev, R
Vandevelde, M
Margery, H
Tassignon, JP
AIDS, 2001, 15 (01) : 33 - 45
[35] Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
Baehner, F
Kampmann, C
Whybra, C
Miebach, E
Wiethoff, CM
Beck, M
JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) : 617 - 627
[36] Early Results from a Prospective Phase II Dose Escalation Study for Neoadjuvant Radiosurgery for Brain Metastases
Murphy, Erin S.
Yang, Kailin
Suh, John
Yu, Jennifer
Schilero, Cathy
Mohammadi, Alireza
Stevens, Glen
Angelov, Lilyana
Barnett, Gene
Vogelbaum, Michael
Neyman, Gennady
Chao, Samuel
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E5 - E5
[37] Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
Gutzmer, R.
Rivoltini, L.
Levchenko, E.
Testori, A.
Utikal, J.
Ascierto, P. A.
Demidov, L.
Grob, J. J.
Ridolfi, R.
Schadendorf, D.
Queirolo, P.
Santoro, A.
Loquai, C.
Dreno, B.
Hauschild, A.
Schultz, E.
Lesimple, T. P.
Vanhoutte, N.
Salaun, B.
Gillet, M.
Jarnjak, S.
Alves, P. M. De Sousa
Louahed, J.
Brichard, V. G.
Lehmann, F. F.
ESMO OPEN, 2016, 1 (04)
[38] A Phase I/II Clinical Trial of Dose Escalation on Biological Target Volume With Intensity Modulated Radiation Therapy: The Long-term Results
Deng, M.
Wu, S.
Huang, S.
Zheng, L.
Fan, W.
Chen, Z.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S8 - S8
[39] Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS
Jacobson, JM
Hafner, R
Remington, J
Farthing, C
Holden-Wiltse, J
Bosler, EM
Harris, C
Jayaweera, DT
Roque, C
Luft, BJ
AIDS, 2001, 15 (05) : 583 - 589
[40] IMMUNOGENICITY AND SAFETY OF THE PRAME CANCER IMMUNOTHERAPEUTIC IN METASTATIC MELANOMA: PHASE I/II DOSE ESCALATION STUDY
Gutzmer, R.
Rivoltini, L.
Levchenko, E.
Testori, A.
Utikal, J.
Ascierto, P. A.
Salaun, B.
Vanhoutte, N.
Gillet, M.
Brichard, V.
ANNALS OF ONCOLOGY, 2012, 23 : 361 - 362

← 1 2 3 4 5 →